FDAFDA · Food and drugs·Recall number D-127-2013
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.
Published January 23, 2013 · Recall initiated: December 10, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
What to do
Voluntary: Firm initiated · Telephone
Recall details
- Manufacturer
- Upsher Smith Laboratories, Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 310162, Exp 09/14
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.